Philip Morris International Inc

PMI’s shift to smoke‑free products, digital‑physical retail, and regulatory‑aligned innovation drives growth and investor confidence.

PMI’s shift to e‑vapor, oral nicotine and digital retail lets it capture Gen Z’s clean‑smoke‑free trend while keeping steady legacy sales—fueling growth and investor confidence in a transforming industry.

Explore how Philip Morris International’s shift to smoke‑free products, e‑vapors, and omnichannel retail is reshaping investor returns and aligning with health‑conscious, ESG‑driven market trends.

PMI declares quarterly dividend, names new Spanish finance director, and faces nicotine‑pouch lawsuit, showing its focus on shareholder returns, smoke‑free shift and regulatory navigation.

PMI’s new CFO, marketing moves, and regulatory scrutiny signal a strategic pivot to smoke‑free products and transparent governance, reshaping its valuation and the nicotine‑replacement market.

PMI’s new CFO, Ferrari partnership and secret EU talks reveal its push beyond cigarettes, but raise regulatory and ESG risks that investors and regulators must weigh.

PMI expands Ferrari partnership, launches premium nicotine pouches, and cuts emissions with new steam‑producing heat pump—boosting brand and ESG impact.

PMI’s Ferrari partnership boosts nicotine‑pouch premium positioning, offering omnichannel retail, digital loyalty, and experiential marketing that drives sales and long‑term growth.

PMI’s CEO joins Morgan Stanley’s consumer conference to unveil its shift to smoke‑free products, ESG‑driven CSR, and investor‑friendly strategy that boosts share price and long‑term growth.

Philip Morris International Inc. reported a strong earnings season, driven by growth in its smoke-free products, including IQOS and Zyn, and raised its annual profit forecast for a third time this year.